Chemomab Therapeutics Ltd. (CMMB) announced the FDA has granted CM-101 Fast Track designation for the treatment in adult patients of primary sclerosing cholangitis, a fibrotic liver disease.
In this episode of Morning Edition, Criminologist Dr. Randy Seepersad weighs in on the proposed anti-crime talks between the Government and the Opposition.
Shares of Lagardere SA (EPA:MMB – Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of €21.06 ($22.89) and traded as high as €21.65 ($23.53). Lagardere shares last traded at €21.45 ($23.32), with a volume of 2,477 shares traded. Lagardere Stock Performance The business’s […]